RXi Pharmaceuticals (RXII.OB) raises a gross $16.4M in a private placement led by OPKO Health (OPK) and Frost Gamma Investments Trust, which is controlled by Teva Chairman Phillip Frost. RXi issues 113M shares at $0.145 each, the same as yesterday's closing price. The firm will also acquire substantially all of OPKO's RNAi-related assets in exchange for 50M shares, as well as milestone and royalty payments.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs